ABCB1 and ABCG2 Restrict Brain and Testis Accumulation and, Alongside CYP3A, Limit Oral Availability of the Novel TRK Inhibitor SelitrectinibWenlong Li, Alfred H. Schinkel, Margarida L.F. Martins et al.|Molecular Cancer Therapeutics|2021Cited by 9